BioRestorative Therapies Inc (OTCMKTS:BRTX) major shareholder Dale Broadrick acquired 3,798,400 shares of the stock in a transaction dated Thursday, October 17th. The shares were acquired at an average cost of $0.13 per share, with a total value of $493,792.00. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Dale Broadrick also recently made the following trade(s):
- On Thursday, August 22nd, Dale Broadrick acquired 175,017 shares of BioRestorative Therapies stock. The shares were acquired at an average cost of $0.28 per share, with a total value of $49,004.76.
OTCMKTS:BRTX opened at $0.15 on Wednesday. The stock has a 50-day simple moving average of $0.21 and a 200-day simple moving average of $0.37. BioRestorative Therapies Inc has a 1 year low of $0.08 and a 1 year high of $1.59.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells for the treatment of disc/spine disease and metabolic disorders. The company's lead cell therapy candidate is the BRTX-100, which focuses on providing non-surgical treatment for protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease.
Further Reading: Moving Average – How it Helps Investors in Stock Selection
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.